Blood flow and metabolism of oligodendrogliomas: A positron emission tomography study with kinetic analysis of 18F-fluorodeoxyglucose

Journal of Neuro-Oncology

Volumn 43, Issue 1, 1999, Pages 49-57

  Mineura, Katsuyoshi ^a,c   Shioya, Hitoshi ^a   Kowada, Masayoshi ^a   Ogawa, Toshihide ^b   Hatazawa, Jun ^b   Uemura, Kazuo ^b  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

18F fluorodeoxyglucose; Kinetic analysis; Oligodendroglioma; Positron emission tomography; Tumor recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; CORPUS CALLOSUM; FEMALE; FOLLOW UP; GRAY MATTER; HEMISPHERE; HUMAN; MALE; METABOLIC RATE; OLIGODENDROGLIOMA; PATHOPHYSIOLOGY; PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KINETICS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; OLIGODENDROGLIOMA; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032815523     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006296729019     Document Type: Article

References (26)

1. Mørk SJ, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R, Harvei S, Ganz J: Oligodendrogliom: incidence and biological behavior in a defined population. J Neurosurg 63: 881-889, 1985
2. Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher VW: A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 19: 15-21, 1986
3. Wilkinson I, Anderson JR, Holmes AE: Oligodendroglioma: an analysis of 42 cases. J Neurol Neurosurg Psychiatry 50: 304-312, 1987
4. Nijjar TS, Simpson WJ, Gadalla T, McCartney M: Oligodendroglioma. The Princess Margaret Hospital Experience (1958-1984). Cancer 71: 4002-4006, 1993
5. Vonofakos D, Marcu H, Hacker H: Oligodendrogliomas: CT patterns with emphasis on features indicating maliganacy. J Comput Assist Tomogr 3: 783-788, 1979
6. Tice H, Barnes PD, Goumnerova L, Scott RM, Tarbell NJ: Pediatric and adolescent oligodendrogliomas. AJNR 14: 1293-1300, 1993
7. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329, 1982
8. Mineura K, Yasuda T, Kowada M, Shishido T, Ogawa T, Uemura K: Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 8: 164-168, 1986
9. Kanno I, Miura S, Yamamoto S, Iida H, Murakami M, Takahashi K, Uemura K: Design and evaluation of a positron emission tomograph: Headtome III. J Comput Assist Tomogr 9: 931-939, 1985
10. Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K, Hirose Y, Amano M, Yamamoto S, Tanaka K: Design and evaluation of Headtome IV, a whole-body positron emission tomograph. IEEE Trans Nucl Sci 37: 1006-1010, 1989
11. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 4: 727-736, 1980
12. Lammertsma AA, Jones T: Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain: 1. Description for the method. J Cereb Blood Flow Metab 3: 416-424, 1983
13. Sasaki H, Kanno I, Murakami M, Shishido F, Uemura K: Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography. J Cereb Blood Flow Metab 6: 447-454, 1986
14. 18F-2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 2: 371-388, 1979
15. 11C]deoxyglucose. J Cereb Blood Flow Metab 5: 179-192, 1985
16. Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K: Positron emission tomography (PET) study in patients with meningiomas. Brain Nerve 42: 145-151, 1990 (Japanese)
17. Lammertsma AA, Wise RJS, Cox TCS, Thomas DGT, Jones T: Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiol 58: 725-734, 1985
18. Patronas NJ, DiChiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816-822, 1985
19. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074-1078, 1988
20. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386-2394, 1994
21. DiChiro G, Hatazawa J, Katz DA, Rizzoli HV, DeMichele DJ: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study. Radiology 164: 521-526, 1987
22. Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss WD: Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 79: 853-858, 1993
23. 18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 29: 347-355, 1991
24. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC, Coleman RE: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17: 509-516, 1993
25. Hölzer T, Herholz K, Jeske J, Heiss WD: FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17: 681-687, 1993
26. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, 2nd edn., Springer-Verlag, Berlin/Heidelberg, 1993